HB 1809-FN (2026): establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

HB 1809-FN (2026)

establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

• Status: Killed
• Term: 2025-2026
• House committee: Health, Human Services and Elderly Affairs
• Senate committee: Health and Human Services
• Subject: Public and Mental Health

The Story

It was introduced on January 7, 2026 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on January 14, 2026, with 9 people signed in online: 4 in support and 5 in opposition. The committee met in executive session on January 28, 2026 to vote on its recommendation. The committee voted unanimously, 18–0, to recommend that the House pass it, and the report was placed on the consent calendar. On February 12, 2026 the House voted to pass it on a voice vote. On February 12, 2026 the bill was referred to the Finance committee. The committee held a work session on March 13, 2026. The committee met in executive session on March 17, 2026 to vote on its recommendation. The majority recommended that the House kill it, and the minority recommended that the House pass it with changes (amendment 2026-1201h), by a vote of 13–11. The report was placed on the regular calendar. On March 26, 2026 the House rejected a motion to kill it on a division vote 127–222. The committee minority's amendment (2026-1201h) was adopted on a division vote 248–101 on March 26, 2026, changing the text of the bill. On March 26, 2026 the House voted to pass it with changes on a voice vote. It crossed to the Senate on March 26, 2026 and was referred to the Senate Health and Human Services committee. The committee held a public hearing on April 8, 2026. The committee voted unanimously, 4–0, to recommend that the Senate kill it. On May 7, 2026 the Senate voted to kill it on a voice vote.

Sponsors

• Rep. Buzz Scherr (D - Rock 26) (prime sponsor)
• Sen. Donovan Fenton (D - SD10)
• Rep. Erica Layon (R - Rock 13)
• Rep. Jennifer Mandelbaum (D - Rock 21)
• Rep. Carol McGuire (R - Merr 27)
• Rep. Matt Sabourin dit Choinière (R - Rock 30)

Hearings and Sessions

• January 14, 2026, 3:00 PM: public hearing, House Health, Human Services and Elderly Affairs, GP 158
• January 28, 2026, 2:30 PM: executive session, House Health, Human Services and Elderly Affairs, GP 158
• February 12, 2026: floor debate, House
• March 13, 2026, 9:00 AM: work session, House Finance, GP 234
• March 17, 2026, 10:00 AM: executive session, House Finance, GP 230
• March 26, 2026: floor debate, House
• April 8, 2026, 9:45 AM: hearing, Senate Health and Human Services, SH 100
• May 7, 2026: consent calendar, Senate

Votes

• February 12, 2026, House: Ought to Pass — voice vote, passed
• March 26, 2026, House: Inexpedient to Legislate — yeas 127, nays 222, failed
• March 26, 2026, House: Adopt Amendment — yeas 248, nays 101, passed
• March 26, 2026, House: Ought to Pass with Amendment 2026-1201h — voice vote, passed
• May 7, 2026, Senate: Inexpedient to Legislate — voice vote, passed

The Docket

From the General Court

• Bill text
• Bill status page
• Docket
• HJ 1, page 37
• HC 6, page 7
• HJ 4, page 7
• HJ 9, pages 42 and 43
• SJ 7
• SC 13
• SC 17
• SJ 11
• House Calendar 12, 2026, committee report